Press Releases

ABBOTT RECEIVES CE MARK FOR AVEIR™ DR, THE WORLD’S FIRST DUAL CHAMBER LEADLESS PACEMAKER SYSTEM

Heart Rhythm 2024 Spotlights New Developments in Cardiac Implantable Electronic Devices and Other Treatments

New clinical trials demonstrate the safety and efficacy of improvements in cardiac implantable electronic devices and complementary pharmacotherapy.

Clinical Trial Shows Early CRT Improves Cardiac Function in Patients with Mild to Moderate Heart Failure, Slowing Disease Progression

This physician-initiated prospective, randomized clinical trial sponsored by The NHLBI found that early CRT may slow the progression of heart failure in patients with mild to moderately reduced LVEF and LBBB

Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™

Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm

MicroPort® CRM Announces the First Implantation of ALIZEA Bluetooth Pacemaker System in the United States

MicroPort® CRM,announces the first implantation in the United States of the ALIZEA™ Bluetooth®1 pacemaker system, a combination of the ALIZEA™ pacemaker generator and VEGA™ pacing leads..